{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:55:30Z","timestamp":1782183330003,"version":"3.54.5"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013427","name":"Samenwerkingsverband Noord-Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtos.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T05:33:55Z","timestamp":1624426435000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2186-8955","authenticated-orcid":false,"given":"Laura E.","family":"Wolpert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1949-2298","authenticated-orcid":false,"given":"Harold","family":"Snieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomdo M.","family":"Jansonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-2620","authenticated-orcid":false,"given":"Christopher J.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Vehof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II Epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2021.06.009_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","article-title":"Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life","volume":"157","author":"Paulsen","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2021.06.009_bib3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archinte.159.12.1359","article-title":"Dry eye and dry mouth in the elderly: a population-based assessment","volume":"159","author":"Schein","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","article-title":"Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study","volume":"31","author":"Chia","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2021.06.009_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","article-title":"Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies","volume":"127","author":"Schaumberg","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2021.06.009_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajo.2012.02.009","article-title":"Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database","volume":"154","author":"Galor","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2021.06.009_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2021.06.009_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10654-007-9204-4","article-title":"Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study","volume":"23","author":"Stolk","year":"2008","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.jtos.2021.06.009_bib12","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jtos.2019.04.004","article-title":"The relationship between occupation and dry eye","volume":"17","author":"Bazeer","year":"2019","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib14","first-page":"539","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2006.02.038","article-title":"Validation and repeatability of a short questionnaire for dry eye syndrome","volume":"142","author":"Gulati","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2021.06.009_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women","volume":"136","author":"Schaumberg","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.009_bib17","series-title":"ATC classification index with DDDs, 2021","year":"2020"},{"key":"10.1016\/j.jtos.2021.06.009_bib18","article-title":"Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in The Netherlands","author":"Vehof","year":"2020","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.jtos.2021.06.009_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1755-3768.2010.01993.x","article-title":"Comorbidities of dry eye disease: a nationwide population-based study","volume":"90","author":"Wang","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtos.2019.11.003","article-title":"Schirmer test results: are they associated with topical or systemic medication?","volume":"18","author":"Hampel","year":"2020","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0528.2010.00588.x","article-title":"Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people","volume":"39","author":"Smidt","year":"2011","journal-title":"Community Dent Oral Epidemiol"},{"issue":"6","key":"10.1016\/j.jtos.2021.06.009_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","article-title":"Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium","volume":"12","author":"Ito","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"issue":"22","key":"10.1016\/j.jtos.2021.06.009_bib23","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2013.280490","article-title":"Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency","volume":"310","author":"Lam","year":"2013","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib24","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.36076\/ppj.2020\/23\/E41","article-title":"An analysis of biomarkers in patients with chronic pain","volume":"23","author":"Gunn","year":"2020","journal-title":"Pain Physician"},{"issue":"12","key":"10.1016\/j.jtos.2021.06.009_bib25","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/bjophthalmol-2014-305201","article-title":"Prevalence and risk factors of dry eye disease in a British female cohort","volume":"98","author":"Vehof","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2021.06.009_bib26","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaophthalmol.2013.4399","article-title":"Relationship between dry eye symptoms and pain sensitivity","volume":"131","author":"Vehof","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2021.06.009_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.pain.2014.05.002","article-title":"Shared genetic factors underlie chronic pain syndromes","volume":"155","author":"Vehof","year":"2014","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jtos.2021.06.009_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut."},{"issue":"2","key":"10.1016\/j.jtos.2021.06.009_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jtos.2019.10.006","article-title":"The gut-eye-lacrimal gland-microbiome axis in Sj\u00f6gren Syndrome","volume":"18","author":"Trujillo-Vargas","year":"2020","journal-title":"Ocul Surf"},{"issue":"7","key":"10.1016\/j.jtos.2021.06.009_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071398","article-title":"Dry eye management: targeting the ocular surface microenvironment","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtos.2021.06.009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heares.2019.107862","article-title":"Associations between tinnitus and glaucoma suggest a common mechanism: a clinical and population-based study","volume":"386","author":"Loiselle","year":"2020","journal-title":"Hear Res"},{"issue":"Pt A","key":"10.1016\/j.jtos.2021.06.009_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/978-1-4615-0717-8_96","article-title":"The role of nitric oxide in ocular surface diseases","volume":"506","author":"Kim","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.niox.2007.04.006","article-title":"Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sj\u00f6gren's syndrome)","volume":"17","author":"Cejkov\u00e1","year":"2007","journal-title":"Nitric Oxide"},{"issue":"11","key":"10.1016\/j.jtos.2021.06.009_bib34","first-page":"CD011194","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jtos.2021.06.009_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2021.06.009_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2021.06.009_bib37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/jop.2013.0216","article-title":"Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers","volume":"30","author":"Iester","year":"2014","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.jtos.2021.06.009_bib39","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0161-6420(92)31847-0","article-title":"Ocular surface alteration after long-term treatment with an antiglaucomatous drug","volume":"99","author":"Herreras","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.06.009_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/OPTH.S28104","article-title":"Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma","volume":"6","author":"Janulevi\u010dien\u0117","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2021.06.009_bib41","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/ICO.0000000000001713","article-title":"Incidence and risk factors of dry eye in a Spanish adult population: 11-year follow-up from the saln\u00e9s eye study","volume":"37","author":"Mill\u00e1n","year":"2018","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2021.06.009_bib42","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/OPX.0b013e318181a947","article-title":"Long-term incidence of dry eye in an older population","volume":"85","author":"Moss","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jtos.2020.04.003","article-title":"Systemic risk factors of dry eye disease subtypes: a New Zealand cross-sectional study","volume":"18","author":"Wang","year":"2020","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/JCP.0000000000001325","article-title":"Influence of different antidepressants on ocular surface in patients with major depressive disorder","volume":"41","author":"I\u015fik-Ulusoy","year":"2021","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.jtos.2021.06.009_bib45","first-page":"205","article-title":"Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features","volume":"2","author":"Marken","year":"2000","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jtos.2021.06.009_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0278-5846(88)90039-5","article-title":"Anticholinergic side effects of tricyclic antidepressants and their management","volume":"12","author":"Remick","year":"1988","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.jtos.2021.06.009_bib47","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/bjophthalmol-2013-303838","article-title":"Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study","volume":"97","author":"Labb\u00e9","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2021.06.009_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/504691","article-title":"Neuroplasticity underlying the comorbidity of pain and depression","volume":"2015","author":"Doan","year":"2015","journal-title":"Neural Plast"},{"issue":"3","key":"10.1016\/j.jtos.2021.06.009_bib49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2017.10.001","article-title":"Neuropathic pain and dry eye","volume":"16","author":"Galor","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.06.009_bib51","doi-asserted-by":"crossref","first-page":"m1315","DOI":"10.1136\/bmj.m1315","article-title":"Pregabalin and gabapentin for pain","volume":"369","author":"Mathieson","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jtos.2021.06.009_bib52","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtos.2021.06.009_bib53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2018.10.001","article-title":"Comorbidities and prescribed medications in patients with or without dry eye disease: a population-based study","volume":"198","author":"Dana","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2021.06.009_bib54","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0528.2010.00554.x","article-title":"Associations between labial and whole salivary flow rates, systemic diseases and medications in a sample of older people","volume":"38","author":"Smidt","year":"2010","journal-title":"Community Dent Oral Epidemiol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:47:01Z","timestamp":1761540421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":54,"alternative-id":["S1542012421000598"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.06.009","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication use and dry eye symptoms: A large, hypothesis-free, population-based study in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}